tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
Holding GMAB?
Track your performance easily

Genmab (GMAB) Income Statement

556 Followers

Genmab Income Statement

Last quarter (Q4 2023), Genmab's total revenue was kr―, a decrease of -100.00% from the same quarter last year. In Q4, Genmab's net income was kr―. See Genmab’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 7.25Bkr 16.47Bkr 14.51Bkr 8.48Bkr 10.11Bkr 5.39B
Cost of Revenue
-kr 226.00M----
Gross Profit
-kr 16.25Bkr 14.51B---
Operating Expense
kr 4.07Bkr 10.93Bkr 8.24Bkr 5.46Bkr 3.80Bkr 2.59B
Operating Income
kr 3.18Bkr 5.32Bkr 6.27Bkr 3.02Bkr 6.31Bkr 2.80B
Net Non Operating Interest Income Expense
kr 1.33Bkr 1.21Bkr 1.00Bkr 184.00Mkr 174.00Mkr 113.00M
Other Income Expense
kr 1.25B-kr 659.00Mkr 781.00Mkr -583.00Mkr -46.00M
Pretax Income
kr 5.76Bkr 5.64Bkr 8.30Bkr 3.98Bkr 5.90Bkr 2.88B
Tax Provision
kr 1.29Bkr 1.28Bkr 1.49Bkr 975.00Mkr 1.15Bkr 719.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 4.47Bkr 4.35Bkr 6.81Bkr 3.01Bkr 4.76Bkr 2.17B
Basic EPS
-kr 66.64kr 83.38--kr 3.44
Diluted EPS
-kr 66.02kr 82.59--kr 3.40
Basic Average Shares
-kr 65.31Mkr 65.39M--kr 629.63M
Diluted Average Shares
-kr 65.91Mkr 66.01M--kr 636.37M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 4.07Bkr 11.15Bkr 8.24Bkr 5.46Bkr 3.80Bkr 2.59B
Net Income From Continuing And Discontinued Operation
kr 4.47Bkr 4.35Bkr 6.81Bkr 3.01Bkr 4.76Bkr 2.17B
Normalized Income
kr 3.49Bkr 4.14Bkr 6.10Bkr 2.42Bkr 5.23Bkr 2.08B
Interest Expense
kr 206.00M--kr 13.00Mkr 10.00Mkr 7.00M
EBIT
kr 5.97Bkr 5.66Bkr 8.28Bkr 4.00Bkr 5.91Bkr 2.87B
EBITDA
kr 5.97Bkr 5.96Bkr 8.65Bkr 4.24Bkr 6.17Bkr 3.00B
Currency in DKK

Genmab Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis